Search Results 1701-1710 of 14804 for anti-TNF drugs

  1. Pillars and Programs - Center for Individualized Medicine - Mayo Clinic Research

    Additionally, this pillar investigates microorganisms with potential therapeutic benefits, validates strategies for gene therapy and analyzes biological age and ...

  2. Difluprednate (Ophthalmic Route) Description and Brand Names - Mayo Clinic

    It is also used to treat an eye condition called endogenous anterior uveitis (eye inflammation). This medicine belongs to the group of medicines known as ...

  3. Antithyroid Agent (Oral Route, Rectal Route) Precautions - Mayo Clinic

    While you are being treated with antithyroid agents, and after you stop treatment with it, do not have any immunizations (vaccinations) without your doctor's ...

  4. Study of RP-3500 With Niraparib or Olaparib in Advanced Solid Tumors - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search tips ... anti-tumor activity. Participation eligibility.

  5. A Study to Evaluate Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Patients - Mayo Clinic

    About this study. The purpose of this study is to evaluate, jointly and independently among patients deemed at higher risk vs. lower risk for disability ...

  6. Fulvestrant (Intramuscular Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  7. Publications - Sean S. Park, M.D., Ph.D. - Mayo Clinic

    Drugs & Supplements · Healthy Lifestyle · Books ... Synthesis and evaluation of anti-PD-L1-B11 ... Minibeam Radiation Therapy Treatment (MBRT): Commissioning and ...

  8. Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the Brain (REACT) - Mayo Clinic

    The temporary use of approved devices during the coiling procedure is allowed, provided their use does not require anti-platelet or other agents affecting ...

  9. Daratumumab And Hyaluronidase-Fihj (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Drugs and Supplements · Daratumumab And Hyaluronidase-Fihj (Subcutaneous Route) ... treatment) multiple myeloma in patients who have received at least 1 previous ...

  10. Nilotinib (Oral Route) Description and Brand Names - Mayo Clinic

    Nilotinib belongs to the general group of medicines known as antineoplastics or cancer medicines. It interferes with the growth of cancer cells, ...